Early use of corticosteroids following car t-cell therapy correlates with reduced risk of high-grade crs without negative impact on neurotoxicity or treatment outcome

HIGHLIGHTS

• who: Tim Lakomy and colleagues from the Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland have published the article: Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome, in the Journal: Biomolecules 2023, 382 of 17/02/2023
• what: This approach has been shown to lower CRS incidence, lower high-grade CRS rates and shorten the duration of CRS symptoms. The authors aimed to assess the consequences of the early use of corticosteroids in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.